NorthCrest Asset Manangement, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1893159
PLYMOUTH, MN
Position in REGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$6,212,329
-$1,532,614 QoQ
Shares Held
9,963
-0.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#30
of 236 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $17,717,995 across 23 Biotechnology names. REGN ranks #1 (35.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9,963 | $6,212,329 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
45,150 | $3,533,890 | |
| 3 | EXEL |
Exelixis, Inc.
|
28,794 | $1,566,681 | |
| 4 | INCY |
Incyte Corp
|
12,026 | $1,363,267 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
15,378 | $844,867 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,554 | $771,918 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
5,414 | $633,816 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
7,974 | $456,272 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,212,329 | 9,963 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $7,744,943 | 10,024 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $9,866,042 | 12,782 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $6,688,763 | 11,896 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,065,850 | 11,554 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $7,549,239 | 11,903 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $8,082,096 | 11,346 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $11,643,534 | 11,076 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $11,356,379 | 10,805 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $10,153,307 | 10,549 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $9,139,485 | 10,406 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $8,580,180 | 10,426 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,506,587 | 10,447 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $8,475,526 | 10,315 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $7,069,880 | 9,799 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $7,169,758 | 10,408 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $6,100,461 | 10,320 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $7,313,155 | 10,471 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $6,245,101 | 9,889 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||